The ability of lentiviral vectors to transfer genes into human hematopoieti
c stem cells was studied, using a human immunodeficiency virus 1 (HIV-1)-de
rived vector expressing the green fluorescence protein (GFP) downstream of
the phosphoglycerate kinase (PGK) promoter and pseudotyped with the G prote
in of vesicular stomatitis virus (VSV). High-efficiency transduction of hum
an cord blood CD34(+) cells was achieved after overnight incubation with ve
ctor particles. Sixteen to 28 percent of individual colony-forming units gr
anulocyte-macrophage (CFU-GM) colonies derived from cord blood CD34(+) cell
s were positive by polymerase chain reaction (PCR) for the GFP gene. The tr
ansduction efficiency of SCID-repopulating cells (SRC) within the cord bloo
d CD34(+) population was assessed by serial transplantation into nonobese d
iabetic/severe combined immunodeficient (NOD/SCID) mice. When 400 000 cord
blood CD34(+) cells were transplanted into primary recipients, all primary
and secondary recipients contained and expressed the transgene. Over 50% of
CFU-GM colonies derived from the bone marrow of these primary and secondar
y recipients contained the Vector on average as deter mined by PCR. Transpl
antation of transduced cells in limiting dilution generated GFP(+) lymphoid
and myeloid progeny cells that may have arisen from a single SRC, Inverse
PCR analysis was used to amplify vector-chromosomal junctional fragments in
colonies derived from SRC and confirmed that the vector was integrated. Th
ese results show that lentiviral vectors can efficiently transduce very pri
mitive human hematopoietic progenitor and stem cells. (C) 2000 by The Ameri
can Society of Hematology.